COVID-19 vaccine candidate shows positive preclinical results
PDS Biotechnology, a clinical stage immunotherapy company, has announced positive results from preclinical testing conducted at the University of Kentucky College of Medicine of its COVID-19 vaccine candidate, PDS0203.
Aug 13, 2020
0
1